HomeSLS • NASDAQ
add
Sellas Life Sciences Group Inc
Previous close
$1.01
Day range
$1.04 - $1.51
Year range
$0.51 - $1.72
Market cap
99.24M USD
Avg Volume
2.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.33M | -21.71% |
Net income | -7.11M | 23.30% |
Net profit margin | — | — |
Earnings per share | -0.10 | 69.70% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.03M | 429.88% |
Total assets | 26.50M | 227.79% |
Total liabilities | 10.61M | -10.91% |
Total equity | 15.89M | — |
Shares outstanding | 70.38M | — |
Price to book | 4.04 | — |
Return on assets | -88.04% | — |
Return on capital | -182.56% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.11M | 23.30% |
Cash from operations | -7.81M | -13.26% |
Cash from investing | — | — |
Cash from financing | 19.69M | 36,362.96% |
Net change in cash | 11.88M | 220.80% |
Free cash flow | -5.53M | 41.67% |
About
Founded
2006
Website
Employees
16
